Last reviewed · How we verify
NCT03918213
Normative Metrics of High-Resolution Anorectal Manometry With the Use of Solid-State Catheter in a Healthy Russian Cohort
NA trial testing High-Resolution anorectal manometry with the use of solid-state catheter in Healthy Subjects in 120 participants. Status unknown.
25 April 2023
Quick facts
| Lead sponsor | Russian Academy of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 120 |
| Start date | 25 April 2019 |
| Primary completion | 25 April 2023 |
| Estimated completion | 25 April 2024 |
| Sites | 2 locations across Russia |
Drugs / interventions tested
- High-Resolution anorectal manometry with the use of solid-state catheter
Conditions studied
- Healthy Subjects — all drugs for Healthy Subjects →
Sponsor
Russian Academy of Medical Sciences — full company profile →
Who can join
Adults 18 to 65, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High resolution anorectal manometry (HRAM) normative values are still need to be studied in different populations and with the use of different (solid-state and water-perfused) systems. No studies on HRAM normative values in a Russian population without signs of functional and organic anorectal pathology has been carried out yet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03918213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Subjects
Currently open trials in the same condition.
- NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
- NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
- NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting
Other Russian Academy of Medical Sciences trials
Trials by the same sponsor.
- NCT06299878 — MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns] · unknown
- NCT04353050 — Atypical MOLes and Melanoma Early Detection Study (MoleMed) · NA · unknown
- NCT04308980 — Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment · Phase 2, PHASE3 · unknown
- NCT04689282 — Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders · Phase 1, PHASE2 · completed
- NCT04252144 — Study of Dietary Patterns and Food Diversity in Russian GERD Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03918213 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Russian Academy of Medical Sciences
- Last refreshed: 3 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03918213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing